Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Villoslada

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
Drug News & Perspectives|December 15, 2010
Biomarkers for multiple sclerosisPablo Villoslada
Investigative Ophthalmology & Visual Science|June 19, 2014
Closing the clinical-radiological paradox using the visual pathway in multiple sclerosisPablo Villoslada
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 6, 2021
Personalized medicine for multiple sclerosis: How to integrate neurofilament light chain levels in the decision?Pablo Villoslada
Journal of Neuroimmunology|January 28, 2012
Data integration and systems biology approaches for biomarker discovery: challenges and opportunities for multiple sclerosisPablo Villoslada, Sergio Baranzini
BMC Systems Biology|November 12, 2014
Autoimmunity and tumor immunology: two facets of a probabilistic immune systemJaime Iranzo, Pablo Villoslada
Archives Italiennes De Biologie|June 25, 2011
Targeting NGF pathway for developing neuroprotective therapies for multiple sclerosis and other neurological diseasesValeria Colafrancesco, Pablo Villoslada
Expert Opinion on Investigational Drugs|April 18, 2020
New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosisPablo Villoslada, Lawrence Steinman
Neurology|August 29, 2022
Preventing Neurodegeneration in Multiple Sclerosis Is Required From the Earliest Stages of the DiseasePablo Villoslada, Sara Llufriu
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2020
The immune signatures of multiple sclerosis: Lessons from twin studiesPablo Villoslada, Scott S Zamvil
Neurology|May 20, 2014
Retrograde trans-synaptic degeneration in MS: a missing link?Robert A Bermel, Pablo Villoslada
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
Drug News & Perspectives|December 15, 2010
Biomarkers for multiple sclerosisPablo Villoslada
Investigative Ophthalmology & Visual Science|June 19, 2014
Closing the clinical-radiological paradox using the visual pathway in multiple sclerosisPablo Villoslada
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 6, 2021
Personalized medicine for multiple sclerosis: How to integrate neurofilament light chain levels in the decision?Pablo Villoslada
Journal of Neuroimmunology|January 28, 2012
Data integration and systems biology approaches for biomarker discovery: challenges and opportunities for multiple sclerosisPablo Villoslada, Sergio Baranzini
BMC Systems Biology|November 12, 2014
Autoimmunity and tumor immunology: two facets of a probabilistic immune systemJaime Iranzo, Pablo Villoslada
Archives Italiennes De Biologie|June 25, 2011
Targeting NGF pathway for developing neuroprotective therapies for multiple sclerosis and other neurological diseasesValeria Colafrancesco, Pablo Villoslada
Expert Opinion on Investigational Drugs|April 18, 2020
New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosisPablo Villoslada, Lawrence Steinman
Neurology|August 29, 2022
Preventing Neurodegeneration in Multiple Sclerosis Is Required From the Earliest Stages of the DiseasePablo Villoslada, Sara Llufriu
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2020
The immune signatures of multiple sclerosis: Lessons from twin studiesPablo Villoslada, Scott S Zamvil
Neurology|May 20, 2014
Retrograde trans-synaptic degeneration in MS: a missing link?Robert A Bermel, Pablo Villoslada
Pageof 21